查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1532927

人類增強市場：2024-2029 年預測

Human Augmentation Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

人類增強市場預計將以 20.44% 的複合年成長率成長，從 2024 年的 2,666.21 億美元增至 2029 年的 6,757.67 億美元。

人類增強技術專注於創造分析和身體改善。這是一個技術主導的過程，旨在提高人類生產力和績效。如果以正確的方式進行擴張，就有可能改善您的整體生活品質。恢復人類能力的“人類能力複製”，例如殘障人士的助聽器；提高執行任務能力的“人類能力複製”，例如用於改善身體素質的人工方法；三種類型：“補充人類能力”，最後是“超人能力”，它們幫助我們做一些我們單獨無法完成的事情，例如飛行的能力。

其中包括增強體力的義肢和外骨骼；增強身體功能或替代受損器官的心律調節器、人工電子耳和胰島素幫浦等植入；以及能夠實現大腦與腦機等外部設備之間直接通訊的植入物。

介紹

人類增強市場主要是由世界各地醫療保健系統的改善和人們對健康生活方式的認知不斷提高所推動的。 GDP 和可支配收入的成長也使人們能夠在健康相關問題上花費更多。此外，綜合醫學方法在北美和歐洲國家廣泛使用和接受。世界各地正在快速進步，以改善不同醫療機構和相關人員之間的合作。

醫療保健基礎設施持續成長。許多國家的醫學研究支出正在增加。美國在這​​一領域仍處於領先地位。由於健康指標的改善和醫療基礎設施的改善，人類增強市場預計將成長。

全球智慧型手機用戶數量正在迅速增加。北美地區的智慧型手機普及率最高。該地區在網路基礎設施和寬頻部署方面投入了大量資金。

人口成長的主要驅動力是育齡人口數量的增加、出生率的顯著變化以及醫療保健設施的增加。光是亞洲就擁有世界人口的五分之三。非洲大陸由人口最多的兩個國家中國和印度組成，兩國人口合計佔世界人口的五分之二。此外，到2022年，據報道，印度智慧型手機用戶數量在過去8年裡從1.5億增加到7.5億。

市場促進因素：

  • 預計全球技術進步的成長將推動市場：

人工智慧和人工智慧、生物技術、奈米技術、機器人技術和材料科學等領域的快速發展正在推動更複雜、更有效的增強智慧解決方案的開發。醫療保健技術的進步也是市場成長的關鍵因素。例如，矯正器具、植入和醫療設備等技術是這些進步的一部分，隨著醫療保健需求的發展，它們被用於改善患者預後、增加活動能力和恢復喪失的功能。因此，人類增強市場預計在預測期內將會成長。

  • 人口老化的加劇和對提高性能的需求預計將推動人類增強市場

世界人口的顯著增加包括患有多種與老年相關的疾病的老年人。因此，與老齡化相關的殘疾和健康狀況的盛行率正在增加，人類增強技術提供了解決與老齡化相關的挑戰（例如行動障礙、感覺障礙和認知能力下降）的解決方案，並可以改善人們的生活品質。

此外，外骨骼、穿戴式裝置和認知增強器等技術擴大用於提高體力、耐力、認知能力和情境察覺，並用於體育、國防、工業等領域的各種應用。人類在不同領域表現的技術的需求不斷成長。

市場限制因素：

除了好處之外，人類增強也為製造它的公司帶來了一些挑戰，包括與使用侵入性手術、植入式設備、增強藥物和生物技術相關的風險。

人們也擔心可能會加劇社會不平等，以及個人範圍的擴大可能會引發有關同意、隱私、公平和公平等複雜的道德和社會問題，這可能會在個人和非擴大範圍之間造成差距。因此，這些因素可能會阻礙預測期內的市場成長。

預計北美地區的成長最為明顯

按地區分類，北美預計主導市場。該地區對生長產品的需求正在增加。此外，該地區正在不斷創新由科技驅動的醫療穿戴產品。北美最大的人類增強市場是美國。北美地區的智慧型手機普及率也最高，預計將提振市場。

美國是北美地區，擁有Google等主要參與者，為該地區的市場成長做出了積極貢獻。因此，由於人們對健康的意識不斷增強，加上醫療設施的改善和智慧型手機用戶數量的增加，北美地區的人類增強市場預計在預測期內將顯著成長。

主要企業提供的產品

B-Temia 提供 Keeogo。 Keeogo 是一款智慧動力矯正器具，可以幫助患有神經系統疾病的人安全、自由地行走。

Ekso Bionics：這種機器人外骨骼是一種支持脊髓損傷患者康復並讓他們恢復體力的設備。

主要進展：

  • 2023年9月，Neuralink宣布將開始招募PRIME（精密機器人植入腦機介面）的臨床試驗。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現
  • 分析師觀點

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章人類增強市場：依產品

  • 介紹
  • 眼鏡產品
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 領帶
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 手腕佩戴
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 鞋類
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 身體穿著
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 其他
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力

第6章人類增強市場：依最終用戶分類

  • 介紹
  • 衛生保健
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 製造業
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 航太/國防
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 其他
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力

第7章人類增強市場：按地區

  • 介紹
  • 北美洲
    • 依產品
    • 按最終用戶
    • 按國家/地區
  • 南美洲
    • 依產品
    • 按最終用戶
    • 按國家/地區
  • 歐洲
    • 依產品
    • 按最終用戶
    • 按國家/地區
  • 中東/非洲
    • 依產品
    • 按最終用戶
    • 按國家/地區
  • 亞太地區
    • 依產品
    • 按最終用戶
    • 按國家/地區

第8章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第9章 公司簡介

  • B-temia
  • Ekaso Bionics
  • Magic Leap Inc.
  • Lifeward
  • Vuzix Corporations
  • Samsung Electronics
  • Raytheon Technologies Corporation
  • Google Inc.
  • BrainGate Inc.
簡介目錄
Product Code: KSI061610261

The human augmentation market is projected to grow at a CAGR of 20.44% to reach US$675.767 billion by 2029 from US$266.621 billion in 2024.

Human augmentation technology focuses on creating analytic and physical improvements. It's a technology-driven process that aims to increase human productivity and capability. If done in the right manner, augmentation has the potential to improve one's overall quality of life. It can be divided into three types: replicating human ability which can restore human ability like a hearing aid for the deaf, there is supplementing human ability which can improve the ability to perform the work, for instance, artificial methods used to increase strength, and at last exceeding human ability that helps to do things that can't be done alone like the ability to fly.

This includes technologies like artificial limbs and exoskeletons that can enhance physical strength, implants such as pacemakers, cochlear implants, and insulin pumps that enhance bodily functions or replace damaged organs, Brain-Computer Interfaces or BCIs that allow direct communication between the brain and external devices, and genetic engineering that allows to modifying genes to enhance desired traits or mitigate genetic diseases.

INTRODUCTION:

The human augmentation market is driven majorly by improving healthcare systems across the globe and growing awareness among people for a healthy lifestyle. The growth in GDP and disposable income is also a contributing factor as people can spend on their health-related issues. Also, the efforts of integrated care have been widely used and accepted in North American and European countries. There is rapid progress taking place across the globe to improve the coordination among the various healthcare settings and stakeholders.

The healthcare infrastructure is improving continuously across the growth. Many countries are increasingly spending on medical research. The United States remains the leading country in this section. With the improving health indices and better healthcare infrastructure, the human augmentation market is expected to witness growth.

The number of smartphone users across the globe is increasing rapidly. North America has the highest penetration of smartphones. This region is investing heavily in network infrastructure and the adoption of broadband.

The population growth is mainly driven by the increasing number of people surviving to the reproductive age, significant changes in the fertility rates, and better healthcare facilities available. Asia constitutes three-fifths of the world's population alone. The continent consists of the two most populated countries- China and India, which together constitute two-fifths of the world's population. Furthermore, in 2022 it was reported that in the last 8 years, the number of smartphone users in India went from 150 million to 750 million.

MARKET DRIVERS:

  • Growth in technological advancements globally is predicted to propel the market:

The rapid advancements in fields such as artificial intelligence or AI, biotechnology, nanotechnology, robotics, and materials science are enabling the development of more sophisticated and effective augmentation solutions. The advancements in healthcare technology are also a significant part of market growth. For instance, technologies like prosthetics, implants, and medical devices are part of these advancements and as healthcare needs evolve, there is a growing demand for advanced solutions to improve patient outcomes, enhance mobility, and restore lost functionalities. Therefore, the human augmentation market is anticipated to grow over the forecast period.

  • The growing aging population and demand for enhanced performance are projected to drive the human augmentation market.

There is a significant increase in the global population which also includes the aging people who have several medical conditions due to old age. This is leading to a higher prevalence of age-related disabilities and health conditions and solutions to address age-related challenges, such as mobility impairments, sensory deficits, and cognitive decline, thereby improving the quality of life for the elderly population can be offered by human augmentation technology.

Also, technologies such as exoskeletons, wearable devices, and cognitive enhancers are increasingly used to improve physical strength, endurance, cognitive abilities, and situational awareness to meet the growing demand for technologies that can enhance human performance in various sectors, including sports, defense, and industry.

MARKET RESTRAINT:

Human augmentation with its benefits also provides some challenges to the companies that manufacture them such as risks associated with invasive procedures, implantable devices, and the use of pharmaceuticals or biotechnologies for enhancement purposes and ensuring the safety and efficacy of human augmentation technologies is paramount which can be challenging for them.

Also, there are some concerns about the potential for exacerbating social inequalities, creating divides between augmented and non-augmented individuals which can raise complex ethical and social questions regarding issues such as consent, privacy, equity, and fairness, and the cost barriers could limit adoption and exacerbate disparities in access to augmentation benefits as human augmentation technologies are expensive and may not be accessible to all individuals. Therefore, these factors might hinder the market growth over the forecast period.

Growth is projected to be prominent in the North American region.

In terms of geography, North America is expected to dominate the market. The region is facing an increasing demand for augmentation products. Moreover, the region is continuously innovating technologically driven medical wearable products. The US represents the largest market for human augmentation in North America. Also, North America constitutes the highest penetration of smartphones which is anticipated to boost the market.

The presence of key players like Google in the USA which is in the North American region is contributing positively to the market growth in the region. Therefore, the awareness among people for health awareness coupled with improving healthcare facilities and increasing smartphone users are anticipated to fuel the North American region human augmentation market significantly over the forecast period.

Products Offered by Key Companies:

B-Temia: The company offers Keeogo which is a smart powered Knee Orthosis that can help people living with neurological conditions to walk safely and freely.

Ekso Bionics: The robotic exoskeleton is a device that can support patients living or recovering from spinal cord injuries and allow them to work on regaining strength back.

Key Developments:

  • In September 2023, Neuralink announced they are open for recruitment for the human trials for PRIME or Precise Robotically Implanted Brain-Computer Interface.

Segmentation:

By Product

  • Eye-wear
  • Neck-wear
  • Wrist-wear
  • Foot-wear
  • Body-wear
  • Others

By End-Users

  • Healthcare
  • Manufacturing
  • Aerospace and Defense
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. HUMAN AUGMENTATION MARKET, BY PRODUCT

  • 5.1. Introduction
  • 5.2. Eye-Wear
    • 5.2.1. Market Trends and Opportunities
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Neck-Wear
    • 5.3.1. Market Trends and Opportunities
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Wrist-Wear
    • 5.4.1. Market Trends and Opportunities
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Foot-Wear
    • 5.5.1. Market Trends and Opportunities
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness
  • 5.6. Body-Wear
    • 5.6.1. Market Trends and Opportunities
    • 5.6.2. Growth Prospects
    • 5.6.3. Geographic Lucrativeness
  • 5.7. Others
    • 5.7.1. Market Trends and Opportunities
    • 5.7.2. Growth Prospects
    • 5.7.3. Geographic Lucrativeness

6. HUMAN AUGMENTATION MARKET, BY END-USERS

  • 6.1. Introduction
  • 6.2. Healthcare
    • 6.2.1. Market Trends and Opportunities
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Manufacturing
    • 6.3.1. Market Trends and Opportunities
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Aerospace and Defense
    • 6.4.1. Market Trends and Opportunities
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Others
    • 6.5.1. Market Trends and Opportunities
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness

7. HUMAN AUGMENTATION MARKET, BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. By Product Type
    • 7.2.2. By End-Users Type
    • 7.2.3. By Country
      • 7.2.3.1. USA
        • 7.2.3.1.1. Market Trends and Opportunities
        • 7.2.3.1.2. Growth Prospects
      • 7.2.3.2. Canada
        • 7.2.3.2.1. Market Trends and Opportunities
        • 7.2.3.2.2. Growth Prospects
      • 7.2.3.3. Mexico
        • 7.2.3.3.1. Market Trends and Opportunities
        • 7.2.3.3.2. Growth Prospects
  • 7.3. South America
    • 7.3.1. By Product Type
    • 7.3.2. By End-Users Type
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
        • 7.3.3.1.1. Market Trends and Opportunities
        • 7.3.3.1.2. Growth Prospects
      • 7.3.3.2. Argentina
        • 7.3.3.2.1. Market Trends and Opportunities
        • 7.3.3.2.2. Growth Prospects
      • 7.3.3.3. Others
        • 7.3.3.3.1. Market Trends and Opportunities
        • 7.3.3.3.2. Growth Prospects
  • 7.4. Europe
    • 7.4.1. By Product Type
    • 7.4.2. By End-Users Type
    • 7.4.3. By Country
      • 7.4.3.1. UK
        • 7.4.3.1.1. Market Trends and Opportunities
        • 7.4.3.1.2. Growth Prospects
      • 7.4.3.2. Germany
        • 7.4.3.2.1. Market Trends and Opportunities
        • 7.4.3.2.2. Growth Prospects
      • 7.4.3.3. France
        • 7.4.3.3.1. Market Trends and Opportunities
        • 7.4.3.3.2. Growth Prospects
      • 7.4.3.4. Spain
        • 7.4.3.4.1. Market Trends and Opportunities
        • 7.4.3.4.2. Growth Prospects
      • 7.4.3.5. Others
        • 7.4.3.5.1. Market Trends and Opportunities
        • 7.4.3.5.2. Growth Prospects
  • 7.5. Middle East and Africa
    • 7.5.1. By Product Type
    • 7.5.2. By End-Users Type
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
        • 7.5.3.1.1. Market Trends and Opportunities
        • 7.5.3.1.2. Growth Prospects
      • 7.5.3.2. UAE
        • 7.5.3.2.1. Market Trends and Opportunities
        • 7.5.3.2.2. Growth Prospects
      • 7.5.3.3. Israel
        • 7.5.3.3.1. Market Trends and Opportunities
        • 7.5.3.3.2. Growth Prospects
      • 7.5.3.4. Others
        • 7.5.3.4.1. Market Trends and Opportunities
        • 7.5.3.4.2. Growth Prospects
  • 7.6. Asia Pacific
    • 7.6.1. By Product Type
    • 7.6.2. By End-Users Type
    • 7.6.3. By Country
      • 7.6.3.1. Japan
        • 7.6.3.1.1. Market Trends and Opportunities
        • 7.6.3.1.2. Growth Prospects
      • 7.6.3.2. China
        • 7.6.3.2.1. Market Trends and Opportunities
        • 7.6.3.2.2. Growth Prospects
      • 7.6.3.3. India
        • 7.6.3.3.1. Market Trends and Opportunities
        • 7.6.3.3.2. Growth Prospects
      • 7.6.3.4. South Korea
        • 7.6.3.4.1. Market Trends and Opportunities
        • 7.6.3.4.2. Growth Prospects
      • 7.6.3.5. Indonesia
        • 7.6.3.5.1. Market Trends and Opportunities
        • 7.6.3.5.2. Growth Prospects
      • 7.6.3.6. Thailand
        • 7.6.3.6.1. Market Trends and Opportunities
        • 7.6.3.6.2. Growth Prospects
      • 7.6.3.7. Taiwan
        • 7.6.3.7.1. Market Trends and Opportunities
        • 7.6.3.7.2. Growth Prospects
      • 7.6.3.8. Others
        • 7.6.3.8.1. Market Trends and Opportunities
        • 7.6.3.8.2. Growth Prospects

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. B-temia
  • 9.2. Ekaso Bionics
  • 9.3. Magic Leap Inc.
  • 9.4. Lifeward
  • 9.5. Vuzix Corporations
  • 9.6. Samsung Electronics
  • 9.7. Raytheon Technologies Corporation
  • 9.8. Google Inc.
  • 9.9. BrainGate Inc.